JP7440736B2 - Medical information processing system, medical information processing program - Google Patents

Description

The present invention relates to a medical information processing system and a medical information processing program that manage medical information including medication information and the like by converting it into electronic data.

Generally, in medical facilities such as hospitals or pharmacies, systems for managing medical information including patient disease information, medication information, test information, etc. (see, for example, Patent Document 1) are sometimes used.

Japanese Patent Application Publication No. 2005-174143

By the way, when a patient's medication information is registered in the system, if the patient is to take multiple specific types of drugs based on the medication information, it is important to note that the occurrence of specific symptoms due to the multiple specific types of drugs is It may be necessary to consider the possibility or extent. For example, when a patient is to take multiple types of psychotropic drugs, the likelihood or degree of specific symptoms (side effects) such as violent behavior, persecution delusion, and delirium due to each psychotropic drug can be evaluated by determining whether chlorpromazine An evaluation value for evaluation as a standard is calculated, and it may be determined whether a total evaluation value obtained by summing up the evaluation values satisfies a preset evaluation standard.

However, conventional systems have not been able to support the task of evaluating the development of specific symptoms caused by multiple specific types of drugs associated with a patient, using predetermined specific components as standards.

An object of the present invention is to provide a medical information processing system and medical information processing system capable of supporting operations for evaluating the occurrence of specific symptoms caused by a plurality of specific types of drugs based on predetermined specific components. The goal is to provide programs.

A medical information processing system according to the present invention includes a calculation processing section and an output processing section. The calculation processing unit calculates the amount of the target drug, which is preset as a calculation target, among the drugs associated with the patient, based on the prescribed amount for the calculation unit number of days, and the equivalent conversion value, which is preset for each target drug. Then, the evaluation value of each of the target drugs is calculated based on the specific component. The output processing section outputs specific information based on a total evaluation value obtained by summing the evaluation values of each of the target drugs calculated by the calculation processing section.

The medical information processing program according to the present invention is a program for causing a computer to execute a calculation step and an output step. The calculation step is based on the prescription amount for the calculation unit days of the target drug preset as the calculation target among the drugs associated with the patient, and the equivalent conversion value preset for each target drug. , calculate the evaluation value of each of the target drugs based on the specific component. The output step outputs specific information based on a total evaluation value obtained by summing the evaluation values of each of the target drugs calculated in the calculation step.

According to the present invention, a medical information processing system and a medical information processing system capable of supporting operations for evaluating the occurrence of specific symptoms caused by a plurality of specific types of drugs based on predetermined specific components. program will be provided.

FIG. 1 is a schematic diagram showing a schematic configuration of a medical information processing system according to an embodiment of the present invention. FIG. 2 is a block diagram showing the detailed configuration of the medical information processing system according to the embodiment of the present invention. FIG. 3 is a diagram showing an example of a drug master used in the medical information processing system according to the embodiment of the present invention. FIG. 4 is a diagram showing an example of a psychotropic drug classification master used in the medical information processing system according to the embodiment of the present invention. FIG. 5 is a diagram showing an example of a CP conversion master used in the medical information processing system according to the embodiment of the present invention. FIG. 6 is a flowchart showing an example of CP check processing executed by the medical information processing system according to the embodiment of the present invention. FIG. 7 is a diagram showing an example of a screen displayed on the medical information processing system according to the embodiment of the present invention. FIG. 8 is a diagram showing an example of a screen displayed on the medical information processing system according to the embodiment of the present invention. FIG. 9 is a diagram showing a part of a prescription printed by the medical information processing system according to the embodiment of the present invention. FIG. 10 is a flowchart showing an example of psychotropic drug display processing executed by the medical information processing system according to the embodiment of the present invention. FIG. 11 is a diagram showing an example of a screen displayed on the medical information processing system according to the embodiment of the present invention. FIG. 12 is a diagram showing an example of a screen displayed on the medical information processing system according to the embodiment of the present invention.

Embodiments of the present invention will be described below with reference to the accompanying drawings to provide an understanding of the present invention. Note that the following embodiments are examples of embodying the present invention, and are not intended to limit the technical scope of the present invention.

[Medical information processing system 1]
As shown in FIG. 1, a medical information processing system 1 according to an embodiment of the present invention includes a medical information processing device 10 and a plurality of client terminals 20. The medical information processing device 10 and the client terminal 20 can communicate via a network 30 such as a LAN or the Internet.

In this embodiment, a case where the medical information processing apparatus 10 alone is a medical information processing system according to the present invention will be described as an example. On the other hand, it is also conceivable that the medical information processing apparatus 10 and the client terminal 20 perform the processing executed by the medical information processing apparatus 10 in a distributed manner. In this case, the medical information processing device 10 and the client terminal 20 constitute the medical information processing system. Further, the client terminal 20 alone may function as a medical information processing system according to the present invention. For example, it is conceivable that the client terminal 20 acquires necessary information from the medical information processing apparatus 10 as appropriate and realizes the same functions as the medical information processing apparatus 10. In addition, various types of information used in the medical information processing system 1 may be stored in an external server device or the like with which the medical information processing apparatus 10 or the client terminal 20 can communicate via the network 30. In this case, the medical information processing device 10 or the client terminal 20 reads various information from the external server device and stores the various information in the external server device.

[Medical information processing device 10]
As shown in FIG. 2, the medical information processing device 10 is a computer system including a control section 11, a storage section 12, a display section 13, an operation section 14, a communication IF 15, a drive device 16, etc. Functions as a server for system 1. Note that the medical information processing device 10 is provided inside or outside a medical-related facility such as a hospital or pharmacy where the medical information processing device 10 is used.

The medical information processing device 10 according to the present embodiment includes an electronic medical record system that manages medical information (electronic medical record) including patient disease information, medication information, test information, etc., and prescription data indicating the patient's prescription details. It functions as a dispensing support system that manages. The medication information includes information such as drug identification information (generic name, YJ code, brand name, etc., the same applies hereinafter), dosage, and usage of the drug to be administered to the patient. The usage includes information indicating the timing and period for which the patient takes the drug, such as "3 minutes after breakfast, 7 days' worth".

For example, in the medical information processing apparatus 10, medical information is registered according to the operation of the client terminal 20, and prescription data is issued based on the medication information included in the medical information. Similar to the medication information, the prescription data includes information such as drug identification information, dosage, usage, and prescription date (issue date) of the drug. Further, the medical information may include medicine information regarding medicines that the patient brings with him or her at the time of the first consultation at the medical-related facility. The medicine information includes information such as medicine identification information, dosage, usage, prescription period, etc. of the medicine. The prescription period is information indicating a period during which the patient takes the medicine, and is information indicating the start date and number of days of the period, or information such as the end date of the period. Thereby, the medical information processing device 10 can specify information on drugs that are associated with a patient and that the patient is currently taking, based on the medical information and the prescription data. . Note that the dispensing support system is installed in an external pharmacy or the like separately from the medical information processing device 10, and the prescription data or the medicine information, etc., is transmitted from the medical information processing device 10 to the external dispensing support system. May be sent.

The control unit 11 includes control devices such as a CPU, ROM, RAM, and EEPROM (registered trademark). The CPU is a processor that executes various types of arithmetic processing. The ROM is a non-volatile storage section in which information such as control programs for causing the CPU to execute various processes is stored in advance. The RAM is a volatile storage section, and the EEPROM is a nonvolatile storage section. The RAM and the EEPROM are used as temporary storage memory (work area) for various processes executed by the CPU. The control unit 11 uses the CPU to execute various processes according to various control programs stored in advance in the ROM, the EEPROM, or the storage unit 12.

The storage unit 12 is a nonvolatile storage unit such as a hard disk, an SSD, or a flash memory in which various control programs and various data executed by the control unit 11 are stored. For example, the storage unit 12 has storage areas such as a program area 121, a data area 122, and a master area 123.

The program area 121 stores a medical information processing program for causing the control unit 11 to execute various processes. Note that the program area 121 also stores application programs such as an operating system (OS) and browser software.

In the data area 122, the medical information, the prescription data, and the like are accumulated and stored. The medical information is registered or edited in the medical information processing device 10 according to a user operation using the client terminal 20, for example.

The master area 123 stores various types of master information such as a drug master D1, a psychotropic drug classification master D2, and a CP conversion master D3. Here, FIGS. 3 to 5 are diagrams showing examples of the drug master D1, the psychotropic drug classification master D2, and the CP conversion master D3. In addition, as another embodiment, information similar to the psychotropic drug classification master D2 or the CP conversion master D3 is registered in the drug master D1, and various processes are executed using the drug master D1. Good too.

As shown in FIG. 3, in the drug master D1, information such as YJ code, common name (component name), brand name, standard amount, etc. is registered as data related to drugs. The YJ code is a 12-digit individual drug code that can identify the drug. For psychotropic drugs, the first 7 digits of the YJ code indicate the psychotropic drug classification (anxiolytics, sleeping pills, antidepressants, antidepressants). psychotic drugs). Note that the YJ code is a code that is further subdivided from the drug price list drug code. In this embodiment, a case will be described in which the classification of the psychotropic drug is specified by the first seven digits of the YJ code, but in another embodiment, the classification of the psychotropic drug is specified using the drug price list drug code. may also be identified.

As shown in FIG. 4, the psychotropic drug classification master D2 contains information such as the first seven digits of the YJ code, common name, and classification for each predetermined drug classified as a psychotropic drug. are registered in association with each other. That is, in the psychotropic drug classification master D2, the classification code of the first seven digits (specific number of digits) included in the YJ code (drug code) for identifying drugs corresponds to the predetermined psychotropic drug classification. It is attached. The control unit 11 can edit the psychotropic drug classification master D2 according to user operations on the medical information processing device 10 or the client terminal 20. Further, the psychotropic drug classification master D2 may be updated by the control unit 11 based on information read from a recording medium such as a DVD by the drive device 16.

For example, a drug whose first seven digits of the YJ code is "1124013" is classified as an "anxiolytic drug," and a drug whose first seven digits of the YJ code are "1124007" is classified as a "sleeping drug." Further, drugs whose first seven digits of the YJ code are "1179001" are classified as "antidepressants," and drugs whose first seven digits of the YJ code are "1179024" are classified as "antipsychotics." Therefore, in the medical information processing device 10, the control unit 11 determines whether each drug registered in the drug master D1 corresponds to a psychotropic drug, based on the psychotropic drug classification master D2. It is possible to do so. Further, the control unit 11 determines whether each of the psychotropic drugs is classified as an anxiolytic drug, a sleeping pill, an antidepressant drug, or an antipsychotic drug, based on the psychotropic drug classification master D2. Is possible. In this way, the control unit 11 can determine the classification of the psychotropic drug using the 7-digit code, which is less than the total number of digits of the YJ code.

As shown in FIG. 5, in the CP conversion master D3, drugs are preset as drugs that require evaluation for specific symptoms (side effects) such as ferocity, persecution delusion, and delirium in the CP check process described later. For each target drug, information such as YJ code, brand name, and equivalent conversion value is registered in association with each other. Note that information on the standard amount may be included in the CP conversion master D3. The control unit 11 can edit the CP conversion master D3 according to user operations on the medical information processing device 10 or the client terminal 20. Further, the control unit 11 may update the CP conversion master D3 based on information read from a recording medium such as a DVD by the drive device 16 or information downloaded via the network 30.

The equivalent conversion value is a value used to evaluate the possibility or degree of the occurrence of the specific symptom based on chlorpromazine, which is a predetermined specific component. In this embodiment, a case where the specific component serving as the evaluation standard is chlorpromazine will be described as an example. Specifically, the equivalent conversion value is a value indicating the amount of the main component of the target drug when the possibility or degree of the occurrence of the specific symptom is equivalent to "100 mg" of the chlorpromazine. For example, for "Timiperone Tablets 3 mg" shown in FIG. 5, the equivalent conversion value is "1.3", which means that the possibility or degree of the specific symptoms occurring per unit dose is higher than that of chlorpromazine. I understand. That is, the lower the equivalent conversion value of a drug is, the higher the possibility or degree of the specific symptom will appear per unit dose, and the higher the equivalent conversion value of the drug is, the higher the possibility or degree of the occurrence of the specific symptom per unit dose. etc. are low.

Note that in the CP conversion master D3 used in this embodiment, the table information is registered for each brand name of a drug, and therefore a 12-digit YJ code is used as drug identification information for the drug. On the other hand, as another embodiment, it is conceivable that the equivalent conversion value is registered for each common name of a drug in the CP conversion master D3, and in this case, the upper 7 of the YJ code is used as the identification information of the drug. A digit classification code is used.

The display unit 13 is a display unit such as a liquid crystal display or an organic EL display that displays various information according to control instructions from the control unit 11. The operation unit 14 is an operation unit operated by a user to input various information to the medical information processing device 10. Specifically, the operation unit 14 includes a keyboard and a mouse (pointing device) that accept input operations on various operation screens displayed on the display unit 13. Further, the operation unit 14 may include a touch panel that accepts touch operations on various operation screens displayed on the display unit 13, or a voice input device that accepts input of various information through voice recognition.

The communication IF 15 is a communication interface having a network card or the like that performs wireless or wired data communication with an external device such as the client terminal 20 via the network 30 according to a predetermined communication protocol.

The drive device 16 can read information such as the medical information processing program from a computer-readable recording medium 161 on which the medical information processing program and the like are recorded. The recording medium 161 is a CD, DVD, BD, or USB memory, and the drive device 16 is a CD drive, a DVD drive, a BD drive, a USB port, or the like. In the medical information processing apparatus 10, the control unit 11 stores the medical information processing program read from the recording medium 161 using the drive device 16 in the program area 121.

By the way, when a patient's medication information is registered in the system, if the patient is to take multiple specific types of drugs based on the medication information, it is important to note that the occurrence of specific symptoms due to the multiple specific types of drugs is It may be necessary to consider the possibility or extent. For example, when a patient is to take multiple types of psychotropic drugs, the possibility or degree of the occurrence of specific symptoms such as violent behavior, persecution delusion, and delirium due to each psychotropic drug is evaluated using chlorpromazine as a standard. It may be determined whether or not a total evaluation value obtained by calculating evaluation values and summing the evaluation values satisfies preset evaluation criteria. However, conventional systems have not been able to support the task of evaluating the development of specific symptoms caused by multiple specific types of drugs associated with a patient, using predetermined specific components as standards. In contrast, the medical information processing system 1 according to the present embodiment supports the work for evaluating the occurrence of specific symptoms caused by a plurality of specific types of drugs based on predetermined specific components. is possible.

Specifically, in the medical information processing apparatus 10, the control section 11 includes a calculation processing section 111, an evaluation processing section 112, an output processing section 113, a change processing section 114, and a presentation processing section 115. Specifically, the control unit 11 functions as various processing units by executing various processes according to the medical information processing program. Note that when the control unit 11 includes a plurality of processors, various processes according to the medical information processing program may be executed in parallel by the plurality of processors.

The calculation processing unit 111 calculates the prescription amount for the calculation unit days of the target drug preset as the calculation target among the drugs associated with the patient, and the equivalent conversion value (preset for each target drug). (see FIG. 5), calculate the CP conversion value of each of the target drugs using chlorpromazine as a reference. Note that the CP conversion value is an example of an evaluation value according to the present invention. In this embodiment, a case will be described in which the calculation unit number of days is one day. Further, the prescribed amount is a value calculated by multiplying the dose of the target drug by the standard amount of the target drug, and is a value indicating the amount of the main component of the target drug. The dose is, for example, a value indicating the number of tablets per day when the prescription unit of the target drug is one tablet. Note that when the prescription amount is input as the medication information, the prescription amount may be used to calculate the CP conversion value.

Specifically, the calculation processing unit 111 extracts one or more target drugs registered in the CP conversion master D3 from the drugs associated with the patient as drugs taken by the patient. Then, for each of the target drugs, the calculation processing unit 111 multiplies the prescribed amount of the target drug for one day (calculation unit number of days) by the equivalent conversion value of the target drug by 100. The CP conversion value is calculated (CP conversion value=[prescription amount/equivalent conversion value]×100).

In particular, in the present embodiment, the calculation processing unit 111 extracts each of a first type target drug, a second type target drug, and a third type target drug as the target drugs associated with the patient. , it is possible to calculate the CP conversion value for each of the target drugs.

The first type target drug is a drug included in the medication information currently input in association with the patient. The second type target drug is a drug whose prescription period based on the past medication information or prescription data associated with the patient has not ended. The third type target drug is a drug that is input as a drug to be taken by the patient in addition to the drug prescribed to the patient based on the medication information input in the medical information processing system 1, and is a drug that is input as a drug to be taken by the patient. The drug has not expired. That is, the third type target drug is a drug included in the brought-in medicine information as the brought-in medicine. Note that the medical information processing system 1 may be provided with a medical questionnaire terminal for the patient to input information on the medical questionnaire, and when the patient inputs the medicines he/she is taking into the medical questionnaire terminal, In this case, when the drug is registered in the CP conversion master D3, the drug may be processed as the third type target drug.

In addition, as another embodiment, the CP conversion value is calculated only for the first type target drug and the second type target drug as the target drugs, and the first type target drug and the third type target drug It is also conceivable that the CP conversion value is calculated only for the target drug, or that the CP conversion value is calculated for only the first type target drug.

Further, in this embodiment, a case where the calculation unit number of days is one day will be described as an example, but in other embodiments, it may be two or more days. Furthermore, in this embodiment, the drugs registered in the CP conversion master D3 are extracted as the target drugs, but whether or not they are the target drugs is determined based on the first seven digits of a preset YJ code, for example. may be determined.

The evaluation processing unit 112 evaluates the total CP conversion value, which is the sum of the CP conversion values of each of the target drugs calculated by the calculation processing unit 111, based on one or more preset evaluation criteria. Note that the total CP conversion value is an example of the total evaluation value according to the present invention. Specifically, when only one standard value is set as the evaluation standard, the evaluation processing unit 112 evaluates that the evaluation standard is satisfied when the total CP conversion value is less than the standard value. do. Furthermore, when a plurality of the reference values are set as the evaluation criteria, the evaluation processing unit 112 evaluates to which range the total CP conversion value falls with respect to the plurality of reference values. However, if the total CP conversion value is less than one of the preset reference values, it is evaluated that the evaluation criterion is satisfied.

The output processing unit 113 outputs specific information based on the total CP conversion value. For example, the specific information is one or both of the value itself indicating the total CP converted value and the evaluation result of the total CP converted value by the evaluation processing unit 112. In addition, the output processing unit 113 may output information such as the brand name of the drug, which is the drug identification information of each of the target drugs, and the CP conversion value of each of the target drugs, together with the specific information. In this embodiment, the output processing unit 113 executes processing for displaying the specific information on the client terminal 20. That is, the output mode of the specific information by the output processing unit 113 is display output. For example, the output processing unit 113 causes the client terminal 20 to display the specific information by transmitting display data for displaying the specific information to the client terminal 20. Note that the output processing unit 113 may print out the specific information using a printer.

The change processing unit 114 is capable of receiving a change in the drug type or prescription amount of the first type target drug on an output screen of the total CP conversion value by the output processing unit 113 (conversion simulation screen P2 to be described later), etc. It is. The prescription amount is changed in accordance with a change in the standard amount or dose of the first type target drug. For example, the standard amount of the first type of target drug is changed by selecting the first type of target drug that is the same type of drug but has a different standard amount. Note that when the prescription amount is changed by the change processing section 114, the CP conversion value of the target drug is recalculated by the calculation processing section 111 based on the changed prescription amount, and the calculation processing section The output processing unit 113 outputs the total CP conversion value that is recalculated based on the CP conversion value after the recalculation by 111. As a result, the user can change the currently input drug type or prescription amount of the first type target drug so that the total CP conversion value satisfies the evaluation criteria while referring to the total CP conversion value. is possible.

The presentation processing unit 115 presents the drug type or prescription amount of each of the first type target drugs for which the total CP conversion value satisfies preset evaluation criteria. Specifically, the presentation processing unit 115 uses artificial intelligence to learn the contents of the adjustment of the prescription amount performed by the change processing unit 114 in the past, and based on the learned data, The drug type or prescription amount of each of the first type target drugs for which the total CP conversion value satisfies preset evaluation criteria is automatically calculated and presented. Note that when the drug type of the first type target drug is changed, another first type target drug having the same efficacy as the first type target drug is selected. Further, the learned data is not limited to what has been learned within the medical information processing system 1, but may be generated based on big data etc. collected from a plurality of medical information processing systems 1. good. Thereby, the user can easily change the drug type or prescription amount of the first type target drug so that the total CP conversion value satisfies the evaluation criteria by referring to the content presented by the presentation processing unit 115. is possible.

[Client terminal 20]
On the other hand, as shown in FIG. 2, the client terminal 20 is a computer that includes a control section 21, a storage section 22, a display section 23, an operation section 24, a communication IF 25, a drive device 26, and the like. The client terminal 20 is installed in a hospital examination room, a dispensing room where medicines are prepared, a ward where patients are hospitalized, an accounting counter, etc., and is used by medical professionals such as doctors, pharmacists, nurses, and office staff. It is an operating terminal.

The control unit 21 includes control devices such as a CPU, ROM, RAM, and EEPROM. The CPU is a processor that executes various types of arithmetic processing. The ROM is a non-volatile storage section in which information such as control programs for causing the CPU to execute various processes is stored in advance. The RAM is a volatile storage section, and the EEPROM is a nonvolatile storage section. The RAM and the EEPROM are used as temporary storage memory (work area) for various processes executed by the CPU. The control unit 21 uses the CPU to execute various processes according to various control programs stored in advance in the ROM, the EEPROM, or the storage unit 22.

The storage unit 22 is a nonvolatile storage unit such as a hard disk, an SSD, or a flash memory in which various control programs and various data executed by the control unit 21 are stored. Specifically, the storage unit 22 stores application programs such as an operating system (OS) and browser software. The browser software causes the display unit 23 to display various operation screens based on display data transmitted from the medical information processing device 10 by accessing the medical information processing device 10 via the network 30. In addition, it is application software for transmitting input operations using the operation unit 24 on the operation screen to the medical information processing apparatus 10. For example, when address information such as a URL (Universal Resource Locator) corresponding to the medical information processing device 10 is input to a predetermined position on the operation screen displayed by the browser software, the control unit 21 determines whether the address The medical information processing device 10 is accessed based on the information.

The display unit 23 is a display unit such as a liquid crystal display or an organic EL display that displays various information according to control instructions from the control unit 21. The operation unit 24 is an operation unit operated by a user to input various information to the client terminal 20. Specifically, the operation unit 24 includes a keyboard and a mouse (pointing device) that accept input operations on various operation screens displayed on the display unit 23. Further, the operation unit 24 may include a touch panel that accepts touch operations on various operation screens displayed on the display unit 23, or a voice input device that accepts input of various information through voice recognition.

The communication IF 25 is a communication interface having a network card or the like that performs wireless or wired data communication with an external device such as the medical information processing device 10 via the network 30 according to a predetermined communication protocol. be.

The drive device 26 can read information about the OS or the browser software from a computer-readable recording medium 261 on which the OS or the browser software is recorded. The recording medium 261 is a CD, DVD, BD, or USB memory, and the drive device 16 is a CD drive, a DVD drive, a BD drive, a USB port, or the like. In the client terminal 20, the control unit 21 stores the OS, the browser software, etc. read from the recording medium 261 using the drive device 26 in the program area 221.

In the medical information processing system 1, the medical information processing device 10 and the client terminal 20 constitute a server-client system, and the medical information processing device 10 displays various information in response to user operations on the client terminal 20. Executes processing such as , recording, and printing. That is, the client terminal 20 is used as an operating terminal for the medical information processing apparatus 10, and "display", "operation", "selection", "input", etc. described below are performed by the client terminal. 20 of the display section 23 and the operation section 24 are used.

[CP check processing]
An example of the CP check process executed by the control unit 11 will be described below with reference to FIG. The present invention may be regarded as an invention of a medical information processing method in which part or all of the CP check process is executed by a computer such as the control unit 11. Note that the CP check process described below is just an example, and in other embodiments, some steps of the CP check process may be omitted as appropriate, or other steps may be added.

<Step S1>
In step S1, the control unit 11 determines whether an operation to start the CP check process has been performed. When it is determined that the start operation has been performed (S1: Yes), the process moves to step S2, and until the start operation is performed (S1: No), the process waits at step S1. .

For example, the start operation is performed while the medical record editing screen P1 for the control unit 11 to edit the patient's medical information (electronic medical record) in response to a user operation of the client terminal 20 is displayed.

Here, FIG. 7 is a diagram showing an example of the medical record editing screen P1. As shown in FIG. 7, the medical record editing screen P1 displays a past medical record area D11 in which medical information such as past medication information is displayed, and medical information such as medication information currently being input (current prescription). A current medical record area D12, a patient information area D13 where basic patient information is displayed, and a keypad area D14 where a keypad used for editing the medical information is displayed.

For example, on the medical record editing screen P1, various types of information are recorded as the medical information regarding one consultation, categorized into the following items: "S", "O", "A", "P", and "Guidance". be done. Note that "S" is subjective information, which is information regarding symptoms and the like that are subjectively felt by the patient. "O" is objective information, and is information regarding a doctor's medical findings, test findings, and the like. “A” is assessment information, which is information related to the doctor's evaluation and judgment. "P" is plan information, which is information regarding medication and treatment plans. “Guidance” is instruction information, and is information related to patient education and guidance. In addition, apart from the CP check process, the control unit 11 executes registration process and editing process of patient's medical information in response to user operations using the medical record editing screen P1, but a detailed explanation thereof is given below. Omitted.

Then, as shown in FIG. 7, when the operation tab K1 displayed on the medical record editing screen P1 is operated, the control unit 11 selects candidates for operation contents that are associated with the operation tab K1 in advance. When the operation section K11 corresponding to "CP conversion check" is selected from among the operation contents in the area A11, it is determined that the operation for starting the CP check process has been performed. Further, in response to a right-click operation of the mouse used as the operation unit 24, the control unit 11 displays a window W1 containing candidates for operation contents, as shown in FIG. When the operation section K12 corresponding to "Conversion Check" is operated, it is determined that the start operation of the CP check process has been performed.

Note that the control unit 11 may determine that the start operation of the CP check process has been performed in response to a predetermined operation in the keypad area D14. Furthermore, when the medication information is input as the medical information and the medication information includes the target drug, the control unit 11 responds to a registration operation for registering the medication information as the medical information. It may also be determined that the CP check process is automatically executed.

<Step S2>
In step S2, the control unit 11 selects the target drug registered in the CP conversion master D3 from among the drugs included in the medication information currently input in association with the patient on the medical record editing screen P1. It is extracted as the first type target drug. For example, in the example of the medical record editing screen P1 shown in FIG. 7, the current medical record area D12 contains four items: "Timiperone Tablets 3 mg", "Haloperidol Tablets 3 mg", "Promperidol Tablets 3 mg", and "Mucosta Tablets 100 mg". The type of drug is input as the medication information. On the other hand, only "Timiperone Tablets 3 mg,""Haloperidol Tablets 3 mg," and "Promperidol Tablets 3 mg" are registered in the CP conversion master D3, and "Mucosta Tablets 100 mg" is registered in the CP conversion master D3. If not, only the former "Timiperone Tablets 3 mg", "Haloperidol Tablets 3 mg", and "Promperidol Tablets 3 mg" are extracted as the first type target drugs.

<Step S3>
In step S3, the control unit 11 controls the drug for which the prescription period based on the past medication information or the prescription data associated with the patient has not ended at the time of starting calculation of the current CP conversion value. Then, the target drug registered in the CP conversion master D3 is extracted as the second type target drug. Thereby, it is possible to include the target drug of the second category that may be taken by the patient on the same day as the target drug of the first category as a target for calculating the CP conversion value. Note that the second type target drug is a drug whose prescription period does not end on the start date of taking the drug prescribed based on the medication information input in the current medical record area D12, and which It may be the target drug registered in the conversion master D3.

<Step S4>
In step S<b>4 , the control unit 11 inputs into the brought-in medicine information as a medicine to be taken by the patient in addition to the medicine prescribed to the patient based on the medication information input in the medical information processing system 1 . Therefore, the target medicine whose prescription period has not ended at the time of starting calculation of the CP conversion value and which is registered in the CP conversion master D3 is extracted as a third type target medicine. Thereby, it is possible to also include the target drug of the third category, such as a medicine brought by the patient that the patient may take on the same day as the target drug of the first category, as a target for calculating the CP conversion value. Note that the third type target drug is a drug whose prescription period does not end on the start date of taking the drug prescribed based on the medication information entered in the current medical record area D12, and which It may be the drug information and the target drug registered in the CP conversion master D3.

As described above, in the present embodiment, in steps S2 to S4, the first type target drug, the second type target drug, and the third type target drug are the targets for calculating the CP conversion value in the CP check process. is extracted as On the other hand, as another embodiment, either one or both of steps S3 and S4 may be omitted, that is, either one or both of the second type target drug and the third type target drug is converted into the CP conversion. It may be excluded from the value calculation target.

Note that even if the first type target drug is not extracted in step S2, if the second type target drug or the third type target drug is extracted, the second type target drug or the third type target drug is extracted. The CP conversion values and the total CP conversion values for the three types of target drugs may be calculated, and a conversion simulation screen P2 to be described later may be displayed. Thereby, it is possible to grasp the current total CP conversion value for the second type target drugs, the third type target drugs, etc. before inputting the first type target drugs.

<Step S5>
In step S5, the control unit 11 stores, for each of the target drugs extracted in steps S2 to S4, the daily prescription amount of the target drug and the CP conversion master D3 in association with the target drug. A process for calculating the CP conversion value is executed based on the registered equivalent conversion value. The step S5 is an example of a calculation step according to the present invention, and is executed by the calculation processing section 111 of the control section 11.

Specifically, the control unit 11 specifies the standard amount of the target drug based on the drug master D1, and determines the dose of the target drug based on the medication information, the prescription data, the medicine information, etc. Identify based on Then, the control unit 11 calculates the amount of the main component obtained by multiplying the standard amount of the target drug by the dose as the prescribed amount. Subsequently, the control unit 11 calculates the CP conversion value by dividing the prescription amount of the target drug by the equivalent conversion value of the target drug and multiplying it by 100 (CP conversion value = [prescription amount / equivalent conversion value] x 100).

For example, if the daily dose of the target drug is 3 tablets, the standard amount of the target drug is 3 mg, and the equivalent conversion value is 1.3, the prescribed amount of the target drug is "3 tablets" x "9 mg" of "3 mg" is calculated, and "692.31 mg" obtained by dividing the prescription amount by "1.3" which is the equivalent conversion value and multiplying by 100 is calculated as the CP conversion value. In addition, if the daily dose of the target drug is 3 tablets, the standard amount of the target drug is 3 mg, and the equivalent conversion value is 2, the prescribed amount is "3 tablets" x "3 mg". 9 mg" is calculated, and "450 mg" obtained by dividing the prescribed amount by the equivalent conversion value "2" and multiplying by 100 is calculated as the CP conversion value. In addition, if the main component of the target drug is chlorpromazine, which is the standard for the CP conversion value, the equivalent conversion value is 1, so the daily dose is 1 tablet, and the standard of the target drug is 1. If the amount is 25 mg, "25 mg" is calculated as "1 tablet" x "25 mg" as the prescription amount, and the obtained amount is obtained by dividing the prescription amount by the equivalent conversion value "1" and multiplying by 100. "2500mg" is calculated as the CP conversion value.

Furthermore, among the first category target drugs currently entered in the medication information, the drugs that the patient has been taking may also fall under the second category target drugs or the third category target drugs. be. However, in this case, the first class target drug and the second class target drug or the third class target drug are not taken at the same time, and the second class target drug or the third class target drug is taken. It is considered that the first category target drug is taken after the drug has been administered. Therefore, the control unit 11 excludes, among the first type target drugs, the same drugs as the second type target drugs or the third type target drugs from the targets for calculating the CP conversion value in step S5. . As a result, the total CP conversion value is prevented from becoming excessively large, and wasteful confirmation work by the user is suppressed.

Furthermore, the control unit 11 switches whether or not to exclude the first type target drug, which is the same as the second type target drug or the third type target drug, from the calculation target according to a user operation during initial settings or the like. It may be possible. In another embodiment, the second type target drug or the third type target drug, which is the same as the first type target drug, may be excluded from the calculation target. In addition, as another embodiment, instead of excluding the first type target drug, the second type target drug, or the third type target drug described here from the calculation target of the CP conversion value, may be excluded from the calculation target of the total CP conversion value in step S6.

<Step S6>
In step S6, the control unit 11 executes processing for calculating a total CP conversion value, which is the sum of the CP conversion values of each of the target drugs calculated in step S5. For example, if there are three types of target drugs, the sum of the CP conversion values of the three types of target drugs is calculated as the total CP conversion value.

<Step S7>
In step S7, the control unit 11 executes a process for evaluating the total CP conversion value based on the total CP conversion value and the evaluation criteria set in advance. The step S7 is executed by the evaluation processing section 112 of the control section 11.

In this embodiment, it is assumed that a first reference value and a second reference value smaller than the first reference value are set as the evaluation criteria. For example, the initial value of the first reference value is 1000 mg, and the initial value of the second reference value is 600 mg. Then, the control unit 11 determines whether the total CP converted value is equal to or greater than the first reference value, whether the total CP converted value is less than the first reference value and equal to or greater than the second reference value, and whether the total CP converted value is less than the first reference value and equal to or greater than the second reference value. It is determined whether the total converted value is less than the second reference value. Note that the control unit 11 changes one or both of the first reference value and the second reference value, which are the evaluation criteria, in response to a user operation of the medical information processing device 10 or the client terminal 20. It is possible to do so. The user operation for changing the evaluation criteria may be performed at the time of initial setting, or may be performed while a conversion simulation screen P2 (FIG. 8), which will be described later, is displayed.

<Step S8>
In step S8, the control unit 11 executes an output process of outputting specific information based on the total CP conversion value calculated in step S6. The step S8 is an example of an output step according to the present invention, and is executed by the output processing section 113 of the control section 11.

Specifically, the control unit 11 displays a conversion simulation screen P2 in which the specific information includes the value of the total CP converted value itself and the evaluation result of the total CP converted value in step S7. Displayed on the client terminal 20. Note that the conversion simulation screen P2 is displayed overlappingly on the medical chart editing screen P1, or in place of the medical chart editing screen P1. For example, the evaluation result is displayed in a display manner such as the color scheme or font size of the total CP conversion value. The control unit 11 causes the conversion simulation screen P2 to be displayed on the display unit 23 of the client terminal 20 by transmitting display data for displaying the conversion simulation screen P2 on the display unit 23 of the client terminal 20. Display. Here, FIG. 8 shows an example of the conversion simulation screen P2.

As shown in FIG. 8, the conversion simulation screen P2 includes the brand name, which is the drug identification information, of each of the target drugs, as well as the dose, unit, formula for calculating the CP conversion value, and CP conversion value of the target drug. Displayed. Note that the unit is information indicating the prescription unit of the target drug. For example, when the drug is prescribed in units of tablets, "T" is displayed as the unit.

Further, as shown in FIG. 8, the conversion simulation screen P2 displays the total CP conversion value indicating the total of the CP conversion value of each of the target drugs. Further, on the conversion simulation screen P2, as the evaluation result of the total CP conversion value in step S7, the total CP conversion value is displayed in a color scheme corresponding to the evaluation result. Specifically, when the total CP converted value is less than the first reference value, the control unit 11 displays the total CP converted value in black letters indicating that the prescribed amount is an appropriate amount as the evaluation result. is displayed, and if the total CP conversion value is greater than or equal to the first reference value and less than the second reference value, the evaluation result indicates that the prescribed amount may slightly exceed the appropriate amount. The total CP conversion value is displayed in yellow, and if the total CP conversion value is equal to or higher than the second reference value, red color indicates that there is a strong possibility that the prescribed amount is a large dose as a result of the evaluation. Displays the total CP conversion value. In this way, on the conversion simulation screen P2, the display mode such as the color scheme of the CP conversion value total is changed according to the evaluation result of the CP conversion value total. Therefore, the user can easily understand the evaluation result of the CP converted value total by referring to the display mode of the CP converted value total. Note that the evaluation result may be displayed as characters or images indicating the evaluation result.

In addition, on the conversion simulation screen P2, it is possible to identify whether the information of each target drug belongs to the first type target drug, the second type target drug, or the third type target drug. displayed in the following manner. For example, information on the first category target drug is displayed in the top area A21 with priority over the second category target drug and the third category target drug, and the brand name of the first category target drug is displayed in black. is displayed. In addition, information on the second category target drug is displayed in area A22 at the bottom of the message "Past order history (drugs with the same prescription date as today's)" which indicates that the drug was administered in the past. , the brand name of the applicable Class 2 drug will be displayed in purple. Similarly, the information on the third category target drug is displayed in the area A23 at the bottom of the message "Questionnaire (medications you are currently taking)" indicating that the medicine is the medicine entered in the medicine information. The brand names of Class 3 target drugs are displayed in green.

Note that for the third category target drug, the dose may not be registered in the brought medicine information, and in that case, the control unit 11 calculates the CP conversion value for the third category target drug. Therefore, the dose column corresponding to the third type target drug is displayed in a predetermined color scheme such as red. Thereby, the user can understand that he/she should be careful about the third type target drug.

Further, on the conversion simulation screen P2, an area A26 is displayed in association with each of the target drugs, indicating whether or not the target drugs are to be excluded from the calculation targets of the CP conversion value. Specifically, in the present embodiment, among the one or more target drugs belonging to the first type target drug, the target drug excluded from the calculation target of the CP conversion value in step S5 is set in the area. A26 is displayed in a checked state, and for the target drug that is a calculation target, the area A26 is displayed in an unchecked state. As a result, the user can determine that the target drug whose area A26 is displayed as checked on the conversion simulation screen P2 is subject to calculation because it overlaps with the second type target drug or the third type target drug. It is possible to understand that it is excluded from the For example, in the conversion simulation screen P2, the area corresponding to part or all of the display columns corresponding to each of the target drugs is excluded from the target drugs for which the CP conversion value is calculated and from the calculation target of the CP conversion value. The target drug may be displayed in a display mode such as a background color or text color that allows it to be identified. Specifically, in the conversion simulation screen P2, the display column of target drugs excluded from the calculation target of the CP conversion value may be displayed in gray out.

Note that information regarding the evaluation criteria may be displayed on the conversion simulation screen P2. Specifically, as shown in FIG. 8, on the conversion simulation screen P2, the first reference value is displayed in area A24, and the second reference value is displayed in area A25. Note that the control unit 11 can also change the first reference value or the second reference value used in the medical information processing system 1 according to a user operation in the area A24 or the area A25. .

<Step S9>
In step S9, the control unit 11 determines, on the conversion simulation screen P2, the drug type and prescription amount of the target drug displayed as the first type target drug, and whether or not the target drug is excluded from calculation targets. Accept user operations to change etc. Further, in another embodiment, the control unit 11 controls the current medical record area D12 of the medical record editing screen P1 in response to a change in the drug type or prescription amount of the target drug in step S9. The content of medication information may be updated. The step S9 is executed by the change processing section 114 of the control section 11. Note that if the user operation is not performed in step S9, the process moves to step S10.

For example, the control unit 11 registers the CP conversion master D3 by selecting a brand name column indicating any drug type of the first type target drug on the conversion simulation screen P2. A drug list screen or a drug search screen for arbitrarily selecting the target drug is displayed. Then, the control unit 11 changes the first type of target drug by inputting the target drug selected on the drug list screen, the drug search screen, or the like as the first type of target drug.

Further, the prescribed amount of the target drug is changed by changing the dose of the target drug. For example, in the conversion simulation screen P2, the control unit 11 receives a numerical value input for changing the dose when any dose column of the first type target drug is selected.

Further, in the conversion simulation screen P2, the control unit 11 converts the first type target drug into the CP conversion value in response to a user operation in the area A26 displayed corresponding to the first type target drug. Switch whether or not to exclude it from the calculation target.

In addition, as another embodiment, the control unit 11, when a brand name field indicating any drug type of the target drug of the first type is selected on the conversion simulation screen P2, converts the first type Preferentially displaying one or more specific alternative drugs preset as alternative drugs with the same efficacy as the target drug as selection candidates, or displaying only one or more of the specific alternative drugs as selection candidates. It is possible to do so.

<Step S10>
In step S10, the control unit 11 determines whether a recalculation operation for recalculating the total CP conversion value has been performed. Specifically, the control unit 11 determines that the recalculation operation has been performed when the operation unit K21 displayed on the conversion simulation screen P2 is operated. Here, if it is determined that the recalculation operation has not been performed (S10: No), the process moves to step S11.

On the other hand, if it is determined that the recalculation operation has been performed (S10: Yes), the process returns to the step S5, the CP conversion value is recalculated, and the CP conversion value total is recalculated in the step S6. After that, the specific information including the recalculated CP conversion value, the CP conversion value total, and the evaluation result of the CP conversion value total is displayed on the simulation screen P2. Note that, when the CP conversion value is recalculated in step S5, for the target drug that has been set to be excluded from the calculation target by the user operation in the area A26, the CP conversion value is not calculated at the time of the recalculation. Excluded from the target.

By the way, when step S5 is executed first in the CP check process, when the first type target drug and the second type target drug or the third type target drug are the same medicine, One type of target drug is excluded from the calculation target of the CP conversion value. On the other hand, when recalculating the CP conversion value in step S5 after the recalculation operation in step S10, the user operates the area A26 to select the target drug of the first type and the target drug of the second type, which are the same drug. There is a possibility that both the drug and the third type target drug are intentionally selected as targets for calculating the CP conversion value. Therefore, when the operating section K21 is operated after the area A26 is operated and the step S5 is executed for the second time or later, the control section 11 controls the first type of target drug and the second type of target drug. Even if the drug or the third category target drug is the same drug, the first category target drug is not excluded from the calculation target of the CP conversion value.

In addition, when recalculating the CP conversion value, the CP conversion value is calculated only for the first category target drug, and the CP conversion value is recalculated for the second category target drug and the third category target drug. You don't have to. On the other hand, the configuration may be such that when the second type target drug or the third type target drug needs to be modified, the second type target drug or the third type target drug can be changed. In this case, the CP conversion values may be recalculated for all of the first type target drugs, the second type target drugs, and the third type target drugs, but the CP conversion values may not be changed in the conversion simulation screen P2. The CP conversion value may be recalculated only for the different types.

<Step S11>
In step S11, the control unit 11 performs an AI presentation operation to request an AI presentation process in which prescription amounts of each of the first category target drugs are presented such that the total CP conversion value satisfies the evaluation criteria. Determine whether it has been done or not. Specifically, the control unit 11 determines that the AI presentation operation has been performed when the operation unit K22 displayed on the conversion simulation screen P2 is operated. Here, if it is determined that the AI presentation operation has been performed (S11: Yes), the process moves to step S12, and if it is determined that the AI presentation operation has not been performed (S11: No), the process The process moves to step S13.

<Step S12>
In step S12, the control unit 11 executes an AI presentation process that presents the prescription amount or drug type of each of the first type target drugs for which the total CP conversion value satisfies the evaluation criteria. The step S12 is executed by the presentation processing section 115 of the control section 11.

In the present embodiment, the case where the total CP converted value is a value that satisfies the evaluation standard is the case where the total CP converted value is less than the second reference value set as the evaluation standard. Note that, as described above, the control unit 11 uses, for example, artificial intelligence to learn the contents of the adjustment of the prescription amount or the drug type that was performed by the change processing unit 114 in the past, and Based on the learned data, the prescription amount or the drug type of each of the first type target drugs for which the total CP conversion value satisfies a preset evaluation standard may be automatically calculated and presented. Conceivable. Further, the control unit 11 controls the first type that is input to the simulation screen P2 in response to a reflection operation for reflecting the prescription amount or drug type of the first type target drug presented here. The prescribed amount of the target drug may be changed.

Specifically, the control unit 11 determines the dose of each of the first type target drugs such that the total CP conversion value is less than the second reference value when the drug type of each of the first type target drugs is not changed. It is conceivable to calculate and present it. For example, the control unit 11 calculates a dose of each of the first type target drugs such that the total CP conversion value becomes less than the second reference value by reducing the dose of each of the first type target drugs at the same rate. do. Further, the control unit 11 may reduce the dose of the drug having the largest CP conversion value among the first type target drugs. In addition, it is conceivable that the control unit 11 calculates a plurality of combinations for the doses of each of the first category target drugs for which the total CP conversion value is less than the second reference value, and presents the plurality of combinations. . Further, the control unit 11 presents the drug type of each of the first type target drugs for which the total CP conversion value is less than the second reference value when the dose of each of the first type target drugs is not changed. It's okay. Furthermore, the control unit 11 presents information in which either or both of the dose and drug type have been changed for each of the first category target drugs so that the total CP conversion value is less than the second reference value. It's okay.

<Step S13>
In step S13, the control unit 11 determines whether an end operation for ending the CP check process has been performed. Specifically, when the operation unit K23 displayed on the conversion simulation screen P2 is operated, it is determined that the termination operation has been performed. Then, when it is determined that the termination operation has been performed (S13: Yes), the series of CP check processes is completed and the conversion simulation screen P2 is closed, and then the process is returned to the step S1 and the next step is The start of the CP check process will be awaited. Note that, after the CP check process is completed and the evaluation result is obtained, the control unit 11 may display information by which the determination result can be identified on the medical record editing screen P2. On the other hand, if it is determined that the end operation has not been performed (S13: No), the process returns to step S9.

As explained above, in the medical information processing system 1, when a drug associated with a patient contains one or more of the target drugs, chlorpromazine The specific information based on the total CP conversion value for evaluation based on the CP conversion value is output. Therefore, by referring to the specific information, the user can easily determine whether the prescribed amount of the target drug is appropriate. That is, according to the medical information processing system 1, it is possible to support the work for evaluating the occurrence of the specific symptoms caused by taking multiple types of psychotropic drugs using chlorpromazine as a standard. Further, since the medical information processing system 1 outputs an evaluation result obtained by evaluating the total CP conversion value based on the evaluation criteria, the user can easily understand the evaluation result.

By the way, in the present embodiment, a case has been described in which when the start operation of the CP check process is performed in step S1, steps S2 to S7 are executed and the total CP conversion value is evaluated. On the other hand, as another embodiment, the control unit 11 automatically executes the processes of steps S2 to S7 on the medical record editing screen P1 based on the medication information currently being input into the medical record area D12. Good too. Then, the control unit 11 causes the medical record editing screen P1 to display information that allows identification of the evaluation result in step S7.

Specifically, as shown in FIG. 7, the control unit 11 displays an icon K2 at a predetermined position in the current medical record area D12, and can change the display mode of the icon K2. Conceivable. That is, in the current medical record area D12 of the medical record editing screen P2, the evaluation result can be identified by the icon K2. For example, when the total CP conversion value is equal to or greater than the first reference value, the control unit 11 displays the icon K2 in red indicating this fact. Furthermore, when the total CP conversion value is greater than or equal to the second reference value and less than the first reference value, the control unit 11 displays the icon K2 in yellow to indicate this fact. Furthermore, when the total CP conversion value is less than the second reference value, the control unit 11 displays the icon K2 in blue to indicate this. Note that if the first type target drug is not extracted in step S2, the icon K2 is displayed in gray to indicate this. Thereby, the user can easily grasp the evaluation result of the CP conversion value for the medication information currently being input by referring to the icon K2. Note that the icon K2 is an example of determination result identification information according to the present invention, and the determination result may be displayed as a message or the like instead of the icon K2.

Furthermore, the control unit 11 may display the conversion simulation screen P2 when the icon K2 is operated. Note that the control unit 11 controls the current medical record area D12 when the cursor indicating the operation target on the medical record editing screen moves from the current medical record area D12 to another area after the medication information is input. The display mode of the icon K2 may be changed according to the evaluation result. Further, the control unit 11 may change the display mode of the icon K2 in accordance with the evaluation result every time each of the target drugs is input in the current medical record area D12.

Furthermore, in step S8, a case has been described in which the total CP conversion value and the evaluation result are displayed on the conversion simulation screen P2. On the other hand, when a prescription issued based on the medication information is printed, the control unit 11 uses the specific information including the CP conversion value total, the evaluation result, etc., similarly to the conversion simulation screen P2. It is conceivable to print it on the prescription. Furthermore, the control unit 11 causes the specific information including the CP conversion value total and the evaluation result to be printed on the prescription when the prescription issued based on the medication information is printed. When issuing prescription data based on the medication information, it is conceivable to add the specific information as part of the prescription data. As a result, when a prescription is printed based on the prescription data, the specific information is printed, and the pharmacist etc. can refer to the specific information to evaluate the total CP conversion value. It is.

In another embodiment, the control unit 11 calculates the CP conversion value for each day, which is the calculation unit number of days during the prescription period of the target drug, and adds the total CP conversion value for each day. The specific information based on the information may be output. Specifically, the control unit 11 may print the specific information based on the daily total evaluation value in the prescription period on a prescription issued based on the medication information. Here, FIG. 9 is a diagram showing an example of the specific information printed on the prescription. As shown in FIG. 9, when the prescription period is 7 days, the prescription includes the dose of the target drug for each target drug and the CP conversion value for each day for the prescription period of 7 days. is printed, and the total CP conversion value for each day is also printed. Further, the total CP converted value is printed in a printing mode such as a different color depending on the evaluation result for the total CP converted value. For example, of the total CP converted values, the total CP converted values that are equal to or greater than the first reference value are printed in red text or background.

[Psychotropic drug labeling processing]
Next, a psychotropic drug display process executed by the control unit 11 of the medical information processing device 10 will be described with reference to FIG.

<Step S21>
In step S21, the control unit 11 determines whether or not a medication instruction operation has been performed. Specifically, while the medical record editing screen P1 is displayed, the control unit 11 controls the operation unit K13 corresponding to "medication instruction" in the area A11 displayed on the medical record editing screen P1. or when the operating section K14 corresponding to "medication instruction" is operated in the window W1, it is determined that the medication instruction operation has been performed. When the control unit 11 determines that the medication instruction operation has been performed (S21: Yes), the control unit 11 moves the process to step S22, and until the medication instruction operation is performed (S21: No). , the process is put on standby in step S21.

<Step S22>
In step S22, the control unit 11 sequentially selects one or more drugs included in the medication information currently input on the medical record editing screen P1 each time step S22 is executed, and the process is continued in step S23. to be transferred to Hereinafter, the medicine selected here will be referred to as a determination target medicine.

<Step S23>
In step S23, the control unit 11 specifies the classification of the determination target drug selected in step S22 based on the psychotropic drug classification master D2 (see FIG. 4). For example, in the example shown in FIG. 4, if the first seven digits of the YJ code of the drug to be determined is "1124013", the drug to be determined is a psychotropic drug with the generic name "oxazolam", and its classification is It is identified as an “anxiolytic drug.” Further, if the first seven digits of the YJ code of the drug to be determined is "1124007", it is specified that the drug to be determined is a psychotropic drug "triazolam" and its classification is "sleeping pills." Similarly, if the first 7 digits of the YJ code of the drug to be determined is "1179001", it is determined that the drug to be determined is a psychotropic drug "amoxapine" and its classification is "antidepressant". be done. In addition, if the first seven digits of the YJ code of the drug to be determined is "1179024", the drug to be determined is a psychotropic drug "Zodepine" and its classification is identified as "antipsychotic drug". Ru.

<Step S24>
In step S24, the control unit 11 determines the classification of the psychotropic drug included in the medication information (anxiolytic, sleeping pill, antidepressant, count the number of antipsychotics). Further, in step S24, the total number of drugs classified as either anxiolytics or sleeping pills is also counted.

Note that the number of psychotropic drugs for each category counted in step S24 needs to be calculated using the common name of the drug belonging to the category. Therefore, when counting the number of psychotropic drugs for each category in step S24, for example, if there are two types of drugs with the same generic name in the medication information, the control unit 11 does not count two. Treated as 1 count.

<Step S25>
In step S25, the control unit 11 determines whether the classification has been specified for all the determination target drugs in the medication information. Here, when the control unit 11 determines that the classification has been specified for all the determination target drugs in the medication information (S25: Yes), the process proceeds to step S26. On the other hand, if the control unit 11 determines that the classification has not been specified for all the determination target drugs in the medication information (S25: No), the control unit 11 moves the process to the step S22 and performs the same process. repeat.

<Step S26>
In step S26, the control unit 11 determines whether the gradual reduction condition is satisfied according to the number of psychotropic drugs for each category included in the medication information counted in step S24. Specifically, the control unit 11 determines that the medication information includes any of three or more types of anxiolytics, three or more types of sleeping pills, four or more types of antidepressants, or four or more types of antipsychotics. If so, it is determined that the gradual reduction condition is satisfied. Further, the control unit 11 also determines that the gradual reduction condition is satisfied when the total number of types of psychotropic drugs classified as either an anxiolytic drug or a sleeping drug is three or more.

<Step S27>
In step S27, the control unit 11 displays a medication instruction screen P3 corresponding to the medication instruction operation. Here, FIG. 11 shows an example of the medication instruction screen P3. Note that the medication instruction screen P3 is displayed overlappingly on the medical record editing screen P1, or in place of the medical record editing screen P1.

As shown in FIG. 11, the medication instruction screen P3 includes a prescription display area A31 in which the contents currently input as the medication information in the medical record editing screen P1 are displayed, and A psychotropic drug area A32 in which the number of psychotropic drugs for each category is displayed is displayed.

In particular, the control unit 11 controls, in the psychotropic drug region A32, the psychotropic drug for each of the categories specified in steps S22 to S25, together with the determination result of whether the gradual reduction condition is satisfied in step S26. Display the number. For example, when the gradual reduction condition is satisfied, the control unit 11 displays the determination result by displaying the number of psychotropic drugs in a display format such as a red color indicating this fact. Thereby, the user can easily recognize whether or not the medication information is subject to gradual reduction in medical fee points due to the number of psychotropic drugs, and the reason thereof.

Further, the control unit 11 displays, in the psychotropic drug area A32, a color scheme corresponding to each category of the psychotropic drug displayed in the prescription display area A31. Then, the control unit 11 displays each of the psychotropic drugs in a color scheme corresponding to each category of the psychotropic drug in the prescription display area A31. For example, the control unit 11 displays the background color or text color of the display column for each psychotropic drug in a color corresponding to the classification of the psychotropic drug. Thereby, the user can refer to the prescription display area A31 and the psychotropic drug area A32 and easily understand the classification of each of the psychotropic drugs included in the medication information.

In this way, since the control unit 11 has the function of determining the classification of the psychotropic drug when the drug is the psychotropic drug, the control unit 11 has the function of determining the classification of the psychotropic drug. It is also possible to display the classification of the psychotropic drug in other situations in which it is displayed. For example, when displaying a medication history for a patient based on the medication information or the prescription data, the control unit 11 displays the medication history in the same color scheme as the medication instruction screen P3 on the medication history display screen. Drug identification information such as the brand name of the psychotropic drug may also be displayed. Further, on the drug history display screen, the classification of the psychotropic drug may be displayed in text along with drug identification information such as the brand name of the psychotropic drug. Furthermore, on the display screen of the drug history, the control unit 11 selects one of anxiolytic drugs, sleeping pills, antidepressants, and antipsychotic drugs selected by user operation from among the categories of psychotropic drugs to be displayed. It may be possible to display the drug history only for patients.

[Keep patient switching function]
By the way, in the medical record editing screen P1, editing of the medical information for one patient is executed, but during the editing, it may be desired to edit or refer to the medical information for other patients. On the other hand, the control unit 11 may be equipped with a keep patient switching function that can switch and edit or refer to medical information corresponding to a plurality of patients, and the keep patient switching function will be described below. . Here, FIG. 12 is a diagram showing another example of the medical record editing screen P1.

As shown in FIG. 12, the medical record editing screen P1 includes a consultation list area D15 in which a list of patients waiting for consultation at the medical-related facility is displayed, and medical information of one or more patients being edited. The displayed keep medical treatment area D16 is displayed.

In the consultation list area D15, reception time, waiting time, patient ID, name, kana, age, gender, condition, etc. are displayed for each patient. In the status, a character string indicating the status of the patient's medical examination is displayed; if the patient is not yet examined, it is "waiting for examination", if the examination is in progress, it is "under examination", or editing of medical information is temporarily suspended. If the patient is in a kept state, a character string such as "Keeping medical examination" is displayed.

When an operation for selecting a patient to be examined from the patient list displayed in the consultation list area D15 is performed on the medical record editing screen P1, the control unit 11 selects a patient to be examined from the patient list displayed in the consultation list area D15. Past medical information, current medical information, etc. corresponding to the selected patient are displayed in the past medical record area D11 and the current medical record area D12.

Then, the control unit 11 controls the past medical record area D11 and the current medical record area D12 to display the past medical information and current medical information of the patient (hereinafter referred to as the first patient). It is possible to accept an operation for displaying other patients' medical information while maintaining the input state of the current medical information.

Specifically, when another patient (hereinafter referred to as a second patient) is selected in the consultation list area D15 and the operating unit K3 displayed on the chart editing screen P1 is operated, , while the editing state of the currently displayed medical information of the first patient is temporarily stored in the storage unit 12 or the like, past medical information or current medical information corresponding to the second patient is stored in the medical record. Display it on the editing screen P1.

Further, when the operation unit K3 is operated, the control unit 11 generates a thumbnail image in which the state of the current medical record area D12 temporarily stored as the medical information of the first patient is reduced, and the thumbnail image is The image is displayed in the keep medical treatment area D16 as a keep image D161 corresponding to the first patient. After that, the control unit 11 can also display the plurality of keep images D161 in the keep treatment area D16 in accordance with the selection of a patient in the consultation list area D15 and the operation of the operation unit K3.

Note that the keep image D161 is not limited to one that includes the current medical record area D12, but may be a thumbnail image that includes both the past medical record area D11 and the current medical record area D12. Furthermore, as another embodiment, a preset icon or the like may be displayed as the keep image D161 instead of the thumbnail image.

Then, when the cursor is positioned on the keep image D161 (mouse over), the control unit 11 controls the patient ID, name, kana, age, gender, etc. of the first patient corresponding to the keep image D161. An area D162 showing detailed information is displayed as a pop-up. Furthermore, when an operation for displaying the keep image D161 (double-click operation, drag-and-drop operation to the current medical record area D12, etc.) is performed in the keep medical record area D16, the control unit 11 controls the The medical information of the first patient corresponding to the keep image D161 is redisplayed on the chart editing screen P1.

This allows the user to easily switch and edit the medical information of multiple patients. Further, by displaying the thumbnail image as the keep image D161, it is possible to visually grasp the outline of the medical information of the patient who is currently on hold.

1: Medical information processing system 10: Medical information processing device 11: Control unit 12: Storage unit 13: Display unit 14: Operation unit 15: Communication IF
16: Drive device 161: Recording medium 20: Client terminal 21: Control section 22: Storage section 23: Display section 24: Operation section 25: Communication IF
26: Drive device 261: Recording medium 30: Network

Claims (18)

The prescription amount for the calculation unit days of the target drug that is preset as the calculation target among the drugs indicated by the drug identification information included in the medication information that is input in association with the patient, and the equivalent amount that is preset for each target drug. a calculation processing unit that calculates an evaluation value of each of the target drugs based on the specific component based on the converted value;
an output processing unit that outputs specific information based on a total evaluation value obtained by summing the evaluation values of each of the target drugs calculated by the calculation processing unit;
Equipped with
The calculation processing unit calculates the prescribed amount of the target drug by multiplying the dose of the target drug by a standard amount registered in association with the drug identification information of the target drug included in the medication information. , calculating the evaluation value based on the prescription amount and the equivalent conversion value;
Medical information processing system. The calculation unit number of days is one day,
The specific component is chlorpromazine,
The medical information processing system according to claim 1. The calculation processing unit calculates the evaluation value using a first type target drug currently input as medication information corresponding to the patient as the target drug.
The medical information processing system according to claim 1 or 2. The calculation processing unit calculates a first type target drug that is currently input as medication information corresponding to the patient, and a second type target drug whose prescription period based on the past medication information corresponding to the patient has not ended. and calculating the evaluation value using each as the target drug,
The medical information processing system according to claim 3. The calculation processing unit calculates a first type target drug that is currently input as medication information corresponding to the patient, and a second type target drug whose prescription period based on the past medication information corresponding to the patient has not ended. In addition to the drugs prescribed to the patient based on the medication information input in the medical information processing system, the drugs are entered as drugs to be taken by the patient and the prescription period has not yet expired. Calculating the evaluation value using each of the above as the target drug,
The medical information processing system according to claim 4. The calculation processing unit determines the first type of target drug currently input as medication information corresponding to the patient and the medication to be prescribed to the patient based on the medication information input in the medical information processing system. Calculating the evaluation value for each of the third category target drugs that have been separately input as drugs taken by the patient and whose prescription period has not ended;
The medical information processing system according to claim 3. When the first type target drug is the same as the second type target drug or the third type target drug, the calculation processing unit excludes the first type target drug from the evaluation value calculation target. do,
The medical information processing system according to any one of claims 4 to 6. The output processing unit outputs information on each of the target drugs in a manner that allows the type of the target drug to be identified.
The medical information processing system according to any one of claims 4 to 7. comprising a presentation processing unit that presents the prescription amount or drug type of each of the first type target drugs for which the total evaluation value satisfies preset evaluation criteria;
The medical information processing system according to any one of claims 4 to 8. comprising a change processing unit capable of changing at least one of the prescription amount or drug type of the first type target drug after the output processing unit outputs the total evaluation value;
The calculation processing unit recalculates the evaluation value of the target drug based on the prescription amount or the drug type after the change by the change processing unit,
the output processing unit outputs the total evaluation value after recalculation by the calculation processing unit;
The medical information processing system according to any one of claims 4 to 9. The calculation processing unit calculates the evaluation value for each calculation unit number of days during the prescription period of the target drug,
The output processing unit outputs the specific information based on the total evaluation value for each calculation unit number of days in the prescription period.
The medical information processing system according to any one of claims 3 to 10. The output processing unit prints the total evaluation value for each calculation unit number of days in the prescription period as the specific information on a prescription issued based on the medication information.
The medical information processing system according to claim 11. comprising an evaluation processing unit that evaluates the total evaluation value based on one or more preset evaluation criteria,
The output processing unit outputs the specific information including the evaluation result by the evaluation processing unit.
The medical information processing system according to any one of claims 1 to 12. The output processing unit outputs judgment result identification information that allows identification of the evaluation result to a medical record editing screen for inputting medical information of the patient.
The medical information processing system according to claim 13. The calculation processing unit excludes one or more of the target drugs from calculation targets according to a user operation.
The medical information processing system according to any one of claims 1 to 14. The output processing unit causes the display unit to display the evaluation value for each target drug .
The medical information processing system according to any one of claims 1 to 15. the output processing unit outputs at least the total evaluation value as the specific information;
The medical information processing system according to any one of claims 1 to 16. to the computer,
The prescription amount for the calculation unit days of the target drug that is preset as the calculation target among the drugs indicated by the drug identification information included in the medication information that is input in association with the patient, and the equivalent amount that is preset for each target drug. a calculation step of calculating an evaluation value of each of the target drugs based on the specific component based on the converted value;
an output step of outputting specific information based on a total evaluation value obtained by summing the evaluation values of each of the target drugs calculated in the calculation step;
A medical information processing program for executing
The calculation step calculates the prescribed amount of the target drug by multiplying the dose of the target drug by a standard amount registered in association with the drug identification information of the target drug included in the medication information; calculating the evaluation value based on the prescription amount and the equivalent conversion value;
Medical information processing program .

Images